No spam - just the good stuff

Subscribe to our newsletter

News

Features

‘I want medical tourism to be open to everyone, forever’

Can AI help you live longer?

Standing at the precipice of a biotech renaissance – the confluence of AI and SynBio

The coming together of two of the most transformative technologies of our age will shine a light on our manipulation of biological systems.

Leveraging the past to illuminate longevity for the future

How do environmental factors impact epigenetic age?

Treat the mind, treat the body: Addressing a fundamental gap in acute disease management

Hyperbaric oxygen therapy – a patient’s perspective

Curing aging should be a moral imperative for all of humanity

Meet the founder: Garri Zmudze

‘We’re at the longevity inflection point – and the explosion is coming.’

ARDD: Turning it up to 10

Is the ‘skinny jab’ a new longevity drug?

‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’

‘Healthy Aging and Longevity Forum’ to take place at HKBIO2023 International Convention

1.25 million thank yous

Meet the founder: Carolina Reis Oliveira

TimePie Longevity Forum: More than 40 global longevity speakers to meet in China this December

Edward Norton joins longevity movie’s stellar line-up

Top 3 reasons longevity companies require a new healthcare marketing strategy to attract investors and consumers

Can senotherapeutic peptides reduce skin aging?

Connected technologies are changing the future of aging at home

Impact of epigenetic mechanisms on age-related diseases

Longevity investing: Navigating hype cycles to preserve reputable technologies

From theory to reality: the quest for autophagy boosting drugs

Time to shelve the concept of death?

Rapamycin and its role in aging

Andrew Steele: Curing aging is a question of investment, not time

How can nutrition and physical exercise affect aging?

What is the role of senolytics in cardiac aging?

Rapamycin: mTOR, autophagy and treating mTOR syndrome

How to attract investors: The role of emotional storytelling in longevity investment

Senotherapeutics summit set to pioneer advancements in longevity research

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS

The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.